A win in all six core categories affirms Vetter as a trusted solution provider
- Vetter performs very well in customer-critical aspects
- Results directly reflect the
experience of pharma and biotech companies in working alongside a trusted contractor
- More than 120 service providers assessed to determine the
award recipients
RAVENSBURG, GERMANY - Media OutReach - March 22, 2019 - Life
Science Leader, a leading trade press publication has awarded Vetter, a global
operating Contract Development and Manufacturing Organization (CDMO), in all six
core categories of the 2019 Leadership Award. The award was granted during a
ceremony in New York City on March 20. Unlike other awards, there is no
application process and the winners are determined by customers ranking their
experience with service providers they have actually worked with. Because results
cannot be influenced in any way, the awards signify a high level of
accomplishment that those companies have attained in supporting the needs of pharma
and biotech customers. Vetter won the award in all core award categories -- quality,
expertise, reliability, capabilities, compatibility, and service. This is an
affirmation of the company's hard work in its daily efforts for customers and a
motivation for continued improvement towards excellence as a solution provider.
Pride and
satisfaction in accepting the 2019 CMO Leadership Award.
Oskar Gold, Vetter's Senior Vice President Key Account
Management, Marketing/Corporate Communications
and Customer Project Management.
Picture source: Vetter Pharma International GmbH
"Vetter is thrilled to win this award, particularly in all
six core categories. Together these areas are among the key performance indicators cited by our
customers when doing business with us, and well represent our continuous
efforts to meet their expectations," said Vetter Managing Director Peter
Soelkner. "We are especially pleased to receive
such positive feedback from our customer base in the US, Europe and Asia as it underscores
our efforts to serve the global pharma and biotech markets," added Oskar Gold,
Vetter's Senior Vice President Key Account Management, Marketing/Corporate
Communications and Customer Project Management.
"Each
year, the value that CMOs bring to individual pharma and biotech companies
increases, as does the overall importance of the service sector to our entire
drug development and manufacturing industry," says Louis Garguilo, Chief Editor
and Conference Chair, Outsourced Pharma. "Our congratulations to all of this
year's Award winners -- you keep the industry on the path to further success."
The
CMO Leadership Awards is an annual event now in its eighth year. In determining
the award recipients, Life Science Leader
teams up with Industry Standard Research (ISR) as the research conductor. For
the 2019 award, more than 120 contract manufacturers were assessed by 23
performance metrics in ISR's annual Contract
Manufacturing Quality Benchmarking survey. Participants were recruited from
pharma and biotech companies of all sizes and screened for decision-making
influence related to working with contract manufacturing partners. Respondents
only evaluate those companies with which they have worked on an outsourced
project within the past 18 months. Through this level of qualification, survey
responses are based on actual involvement with contract manufacturers and clear
experiential data.
Find the Vetter press kit and more background information here.
About Vetter
Headquartered in Ravensburg, Germany, Vetter is a global
leading contract development and manufacturing organization (CDMO) with
production facilities in Germany and the United States. Currently employing 4,500 individuals worldwide, the company has long-term
experience in supporting biotechnology and pharmaceutical customers both large
and small. Vetter services range from early stage development support
including clinical manufacturing, to commercial supply and numerous packaging solutions for vials,
syringes and cartridges. As a leading solution provider, Vetter appreciates its
responsibility to support the needs of its customers by developing devices that
contribute to increased patient safety, convenience, and enhanced compliance.
Great importance is also given to social responsibility including environmental
protection and sustainability. Learn more about Vetter at www.vetter-pharma.com.
http://www.media-outreach.com/release.php/View/8281#Contact